Credit Suisse Reinstates Coverage on Teva Pharma (TEVA) at Outperform
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $32.03 -0.59%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE
Credit Suisse reinstates coverage on Teva Pharma (NASDAQ: TEVA) with an Outperform (from Neutral). PT $53.00.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $41.72 yesterday.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $41.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva lawsuit against Eli Lilly over Forteo revived by appeals court
- Hovde Group Starts First Carolina Financial Services (FCBM) at Market Perform
- Desjardins Starts Spartan Delta Corp (SDE:CN) (DALXF) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
